The Maintenance Protocol: What to Do When You've Hit Your Goal and Don't Want to Lose It
The number on the scale was never the finish line. Inside the evidence-based maintenance protocol for keeping GLP-1 weight loss off — with data from the STEP 1 and SURMOUNT-4 trials.
67%
Of lost weight regained within a year of stopping semaglutide cold
89.5%
Kept 80%+ of their loss while continuing tirzepatide (SURMOUNT-4)
14%
Average regain after switching from tirzepatide to placebo
The hard part was supposed to be the climb. You watched the number on the scale fall week after week, learned to trust the quiet that settled over your appetite, and one morning the goal was simply there. Then a different question arrived, softer and a little colder. How do you keep it?
For a long time the story we told about weight was a story with an ending. You reached the number, you closed the book, you moved on. The newest research tells a quieter and more honest version. The number was never the finish line. It was the start of a second discipline, one that almost nobody warned you about.
The good news is that this second phase has a name, a structure, and a growing body of evidence behind it. It is called maintenance, and done well it asks far less of you than the climb did. This is the protocol.
The Science of the Slide
Why the body pulls you back
When you lose a meaningful amount of weight, your body does not celebrate. It treats the loss as a threat. Hunger hormones rise, fullness signals fade, and your resting metabolism settles a little lower than your new size would predict. GLP-1 medications work precisely because they quiet that biology. Take the quieting away suddenly and the old signals come roaring back.
The clearest picture comes from the STEP 1 extension trial. Participants lost an average of 17.3% of their body weight over 68 weeks on semaglutide. Then treatment stopped completely. One year later they had regained two thirds of everything they had lost.
Two thirds of the loss came back not because anyone failed, but because the underlying condition never went away.
What Happens After You Stop — Cold
Body weight relative to starting point, STEP 1 extension. Treatment ended at week 68. *Treatment ends at Wk 68
- Semaglutide group
- Placebo group
Source: Wilding et al., STEP 1 trial extension, Diabetes Obesity & Metabolism (2022), n=327.
This is the single most important thing to understand. Obesity behaves like a chronic condition, closer to high blood pressure than to a broken bone. You do not treat blood pressure for a year and declare yourself cured. The medication manages the condition for as long as you take it, and the same logic now appears to hold here.
Continue vs Stop
The case for staying on, at a lighter touch
The mirror image of STEP 1 is the SURMOUNT-4 trial, which tested what happens when people keep going. After a 36 week lead in on tirzepatide, participants had lost an average of 20.9%. Half then continued the medication and half switched to placebo.
The split was stark. Those who continued lost a further 5.5% on top of what they had already shed. Those who stopped regained 14%. By the end, 89.5% of the people who continued had held on to at least 80% of their original loss. Among those who stopped, only 16.6% managed the same.
Continue or Withdraw: Weight Change After Reaching Goal
Mean body weight change from the maintenance start point, over the following 52 weeks (SURMOUNT-4, JAMA 2024, n=670)
Negative = further loss. Positive = regain. Green bar: continued tirzepatide. Red bar: switched to placebo.
You do not necessarily need the full dose to keep your results, though. Maintenance is often a lighter, gentler version of the protocol that got you here, and that is the heart of this article.
The Protocol
Five moves that hold the line
Maintenance is not a single decision. It is a small set of habits and clinical choices that, stacked together, keep your new weight steady.
Find your maintenance dose — do not just quit
The goal of a maintenance dose is simple. It is the smallest amount of medication that keeps your appetite calm and your weight stable, so you are neither still losing nor creeping back up. For many people this is a step down from their peak dose, sometimes the same compound taken less often. The point is steady medication levels, which also tends to mean fewer side effects.
Taper slowly if you do come off
If you and your clinician decide to reduce or stop, do it gradually rather than all at once. In one program, semaglutide was lowered to zero over nine weeks while people leaned into exercise and diet. A common starting framework is dropping the dose by roughly 10 to 20% per month, with a fallback plan to step back up if hunger or regain returns.
Protect muscle with protein and resistance training
A quarter or more of weight lost on these medications can be lean mass. Muscle is your metabolic engine, so losing it makes maintenance harder. Prioritize protein at every meal and add resistance training a few times a week. There is also intriguing evidence that a structured exercise program after weight loss raises your own natural late phase GLP-1 response by about 25%, which may blunt the rebound in appetite.
Weigh in often and act early
The people who maintain best are the ones who notice drift early. A few pounds is a signal, not a verdict. Regular weigh ins — weekly or biweekly — plus tracking how hungry you feel, turn a slow slide into something you can catch and correct before it compounds.
Keep the relationship with your clinician open
Maintenance dosing is still an evolving, often individualized practice. Lab work, body composition, and honest check ins about hunger and mood are what let you adjust before problems take root rather than after.
Where Lost Weight Goes — and Why Protein Matters
Rough composition of weight lost on GLP-1 therapy without resistance training. Resistance training and adequate protein shift this meaningfully toward fat.
- Fat mass lost
- Lean / muscle mass
- Other
By The Numbers
Stop versus maintain, side by side
The two paths diverge quickly. The table below shows how differently the year after goal unfolds depending on what you do next.
| Outcome at one year | Stopped medication | Continued / maintained |
|---|---|---|
| Average weight regained | ~67% of loss | None — lost 5.5% more |
| Kept 80%+ of weight loss | 16.6% | 89.5% |
| Net loss vs baseline | ~5.6% | ~25.3% |
| Cardiometabolic gains | Drifted back toward baseline | Largely maintained |
| Appetite after change | Returns, often strongly | Stays suppressed |
Sources: STEP 1 extension (semaglutide withdrawal) and SURMOUNT-4 (tirzepatide continuation). Figures rounded.
A Realistic Picture
Not everyone regains, and habits matter
The averages above can feel grim, but they hide real variation. In a large real world analysis of more than 20,000 people who stopped semaglutide, about 17.7% regained all of their lost weight or more, yet more than half stayed roughly where they were or kept losing. The difference came down largely to the habits built while on the medication.
The lesson is not that everyone must stay on forever. It is that the people who hold their results treat the months after goal with the same intention they brought to the climb. Maintenance is not willpower. It is a protocol.
You did not lose the weight by accident, and you will not keep it by accident either.
The reframe that makes maintenance easier
Stop thinking of the medication as a temporary fix you graduate from, and start thinking of it as ongoing care for a chronic condition. That single shift takes the pressure off "ending" and replaces it with the calmer goal of staying steady.
Frequently Asked Questions
Do I have to take a GLP-1 medication forever to keep the weight off?
Not necessarily, but you should plan for the possibility. Obesity behaves like a chronic condition, so for many people some level of ongoing treatment is the most reliable way to maintain. Others successfully taper to a low or zero dose while leaning hard on diet, protein, resistance training, and frequent monitoring. The right answer depends on your body, your history, and your clinician's guidance.
What exactly is a maintenance dose?
It is the lowest dose that keeps your appetite calm and your weight stable, so you are neither still losing nor regaining. It is often lower than your peak weight loss dose, or the same compound taken less frequently. Steady medication levels also tend to mean fewer side effects, which makes long term use more comfortable.
How fast should I taper if I want to come off?
Gradually, never all at once. A common framework is reducing the dose by roughly 10 to 20% per month while strengthening your diet and exercise habits, with a clear fallback plan to step the dose back up if hunger or weight regain returns. One clinical program tapered semaglutide to zero over about nine weeks alongside coaching.
Why do I keep hearing about protein and weight training?
Because a significant share of the weight you lose can be muscle, and muscle is what keeps your metabolism active. Eating enough protein and doing resistance training a few times a week protects that lean mass. There is also evidence that exercise after weight loss can raise your own natural GLP-1 response, which may help control appetite during maintenance.
If I regain a few pounds, have I failed?
No. Small fluctuations are normal and expected. The people who maintain best are simply the ones who notice early and adjust quickly — whether that means tightening habits or revisiting their dose with a clinician. Catching a few pounds is far easier than reversing twenty.
Is microdosing a real maintenance strategy?
Lower dose and reduced frequency approaches are an active area of interest and study for maintenance, since they may control appetite at lower cost with fewer side effects. Because many of these strategies are still being researched or used off label, they should be done with an experienced clinician monitoring your weight, labs, and symptoms rather than on your own.